[1]Villanueva A. Hepatocellular carcinoma [J]. N Engl J Med, 2019, 380(15): 1450-1462.
[2]ForNer A, Reig M, Bruix J. Hepatocellular carcinoma [J]. Lancet, 2018, 391(10127): 1301-1314.
[3]Lu HX, Wei DM, Feng ZhB, et al. Expression and clinical significance of EZH2 in hepatocellular carcinoma [J]. Acta Anatomica Sinica, 2011, 42(1):75-79. (in Chinese)
陆海霞, 危丹明, 冯震博,等. EZH2在肝细胞癌中的表达及临床意义 [J].解剖学报,2011, 42(1): 75-79.
[4]Chen W. Cancer statistics: updated cancer burden in China [J]. Chin J Cancer Res, 2015, 27(1): 1.
[5]Llovet JM, Kelley RK, Villanueva A, et al. Hepatocellular carcinoma [J]. Nat Rev Dis Primers, 2021, 7(1): 6.
[6]Schulze K, Imbeaud S, Letouze E, et al. Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets [J]. Nat Genet, 2015, 47(5): 505-511.
[7]Bayo J, Fiore EJ, Dominguez LM, et al. A comprehensive study of epigenetic alterations in hepatocellular carcinoma identifies potential therapeutic targets [J]. J Hepatol, 2019, 71(1): 78-90.
[8]Gao Q, Zhu H, Dong L, et al. Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma [J]. Cell, 2019, 179(2): 561-577.
[9]Li X, Jiang Y, Meisenhelder J, et al. Mitochondria-translocated PGK1 functions as a protein kinase to coordinate glycolysis and the TCA cycle in tumorigenesis [J]. Mol Cell, 2016, 61(5): 705-719.
[10]Liang C, Shi S, Qin Y, et al. Localisation of PGK1 determines metabolic phenotype to balance metastasis and proliferation in patients with SMAD4-negative pancreatic cancer [J]. Gut, 2020, 69(5): 888-900.
[11]Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal [J]. Sci Signal, 2013, 6(269): pl1.
[12]Chandrashekar DS, Bashel B, Balasubramanya SAH, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses [J]. Neoplasia, 2017, 19(8): 649-658.
[13]Szklarczyk D, Gable AL, Lyon D, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets [J]. Nucleic Acids Res, 2019, 47(D1): D607-D613.
[14]Ren J, Wen L, Gao X, et al. CSS-Palm 2.0: an updated software for palmitoylation sites prediction [J]. Protein Eng Des Sel, 2008, 21(11): 639-644.
[15]Sonnhammer EL, Eddy SR, Durbin R. Pfam: a comprehensive database of protein domain families based on seed alignments [J]. Proteins, 1997, 28(3): 405-420.
[16]Schultz J, Milpetz F, Bork P, et al. SMART, a simple modular architecture research tool: identification of signaling domains [J]. Proc Natl Acad Sci USA, 1998, 95(11): 5857-5864.
[17]HU H, Zhu W, Qin J, et al. Acetylation of PGK1 promotes liver cancer cell proliferation and tumorigenesis [J]. Hepatology, 2017, 65(2): 515-528.
[18]Nie H, Ju H, Fan J, et al. O-GlcNAcylation of PGK1 coordinates glycolysis and TCA cycle to promote tumor growth [J]. Nat Commun, 2020, 11(1): 36.
[19]Hoekema A, Kastelein RA, Vasser M, et al. Codon replacement in the PGK1 gene of Saccharomyces cerevisiae: experimental approach to study the role of biased codon usage in gene expression [J]. Mol Cell Biol, 1987, 7(8): 2914-2924.
[20]Hansen RS, Gartler SM. 5-Azacytidine-induced reactivation of the human X chromosome-linked PGK1 gene is associated with a large region of cytosine demethylation in the 5’ CpG island [J]. Proc Natl Acad Sci USA, 1990, 87(11): 4174-4178.
[21]Gao S, Drouin R, Holmquist GP. DNA repair rates mapped along the human PGK1 gene at nucleotide resolution [J]. Science, 1994, 263(5152): 1438-1440.
[22]Tan MJ, Luo H, Lee S, et al. Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification [J]. Cell, 2011, 146(6): 1015-1027.
[23]Qian X, Li X, Shi Z, et al. PTEN suppresses glycolysis by dephosphorylating and inhibiting autophosphorylated PGK1 [J]. Mol Cell, 2019, 76(3): 516-527.
|